$10.730
-0.329 (-3.07%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ARCT por análisis de gráficos similares
Alphio's ARCT stock price prediction model matches the current Arcturus Therapeutics Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.93 (+0.88%). The 1-week path is $10.04 (+2.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Arcturus Therapeutics Holdings Inc?
Arcturus Therapeutics (ARCT) is a good buy right now due to its recent positive clinical trial results for ARCT-810, which showed promising safety and efficacy, and the stock's current price of $10.34 being significantly below analyst price targets of $20. The RSI is at a low 23.36, indicating potential for a rebound. However, the company has reported substantial net losses, with a net income of -$23,785,000 in Q2 2026, which remains a risk.
ARCT cerró en $10.73 el Thursday, tras bajar -3.07%
Arcturus Therapeutics Holdings Inc (ARCT) last closed at $9.84, losing -8.29%. These facts feed the 1-day and 1-week ARCT price prediction above.
Consenso de analistas
Arcturus Therapeutics Holdings Inc (ARCT): 1 comprar, 1 mantener, 1 vender. Perspectiva: Hold.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Arcturus Therapeutics Holdings Inc (ARCT) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ARCT, ordenadas por similitud.
Análisis de estacionalidad de ARCT
Historically the probability of a positive October return for ARCT is 50.79%. February offers the highest probability of a positive month at 77.59%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ARCT
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $8.02 | $8.11 | $9.20 | -17.58% |
| Nov 2026 | $7.44 | $9.58 | $10.34 | -2.69% |
| Dec 2026 | $7.73 | $9.33 | $9.77 | -5.23% |
En 2026, se proyecta que Arcturus Therapeutics Holdings Inc (ARCT) oscile entre $7.44 y $10.34.
Previsión mensual de Arcturus Therapeutics Holdings Inc para 2026
En Oct de 2026, se proyecta que Arcturus Therapeutics Holdings Inc promedie $8.11, con un mínimo de $8.02 y un máximo de $9.20.
En Nov de 2026, se proyecta que Arcturus Therapeutics Holdings Inc promedie $9.58, con un mínimo de $7.44 y un máximo de $10.34.
En Dec de 2026, se proyecta que Arcturus Therapeutics Holdings Inc promedie $9.33, con un mínimo de $7.73 y un máximo de $9.77.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.